Brevican (BCAN) (Middle Region) Peptide
BCAN
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BCAN products
- BCAN (Brevican (BCAN))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- PTETLPTPRE RNLASPSPST LVEAREVGEA TGGPELSGVP RGESEETGSS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCAN Antibody(ARP57797_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCAN (Brevican (BCAN))
- Synonyms
- fi32a12 Peptide, wu:fi32a12 Peptide, BCAN Peptide, Xbcan Peptide, Cspg7 Peptide, ALPBRE Peptide, BEHAB Peptide, CSPG7 Peptide, brevican Peptide, brevican L homeolog Peptide, bcan Peptide, BCAN Peptide, bcan.L Peptide, Bcan Peptide
- Background
-
The function of this protein remains unknown.
Alias Symbols: BEHAB, CSPG7, MGC13038
Protein Interaction Partner: ADAMTS4,FBLN2,MMP1,MMP10,MMP13,MMP2,MMP3,MMP7,MMP8,TNR,FBLN2,MMP1,MMP10,MMP13,MMP2,MMP3,MMP7,MMP8
Protein Size: 671 - Molecular Weight
- 72 kDa
- Gene ID
- 63827
- NCBI Accession
- NM_198427, NP_940819
- UniProt
- Q96GW7
-
You are here:
